**Sorry! Had to take down this episode and repost it as Mark's voice was somehow muted when Matt exported the file. Fixed now!**

Today Stephen, Mark, and Matt chat about the promising antiviral remdesivir and the ethical dimensions of clinical trials.

Please consider supporting us to help upgrade our equipment and offload our editing responsibilities:

• Give monthly (as little as $5 a month) on our Patreon Page
• Give a one time gift through Venmo at @mattboettger
• Give a one time gift through PayPal here.

Related Articles from Episode:

• A running list of Stephen’s interviews
• Lancet article Mark referenced
• Atlantic article Matt referenced

Want more information on Matt's Living the Real website?
Please click here to sign up for his newsletter and get information when his blog and podcast will launch.

Support the show